Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026)
Ardelyx's (ARDX) quarterly Amortizatization of Intangibles came in at $1.6 million in Q1 2026, down 25.94% YoY from $2.1 million in Q1 2025, and down 23.98% on a QoQ basis from $2.1 million in Q4 2025.
Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Ardelyx (ARDX) has 11 years of Amortizatization of Intangibles data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 25.94% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (up 7.98% YoY) and the FY2025 annual result came in at $9.0 million, up 21.05% from the prior year.
- Amortizatization of Intangibles eased to $1.6 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.5 million in Q3 2025 to a low of $42000.0 in Q2 2022.
- A 5-year average of $1.4 million and a median of $1.6 million in 2026 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles plunged 85.91% — and 2023, when it soared 2390.48%.
- Tracing ARDX's Amortizatization of Intangibles over 5 years: stood at $907000.0 in 2022, then climbed by 24.26% to $1.1 million in 2023, then jumped by 75.69% to $2.0 million in 2024, then advanced by 5.1% to $2.1 million in 2025, then fell by 23.98% to $1.6 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.6 million (Q1 2026), $2.1 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.75 Mn |